The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on mifepristone given its “25-year safety record.”

Four blue states are asking the U.S. Food and Drug Administration to remove restrictions on a key abortion medication and make it easier for clinicians to prescribe and dispense it - an attempt to widen access as the agency plans to review the pill’s safety.